Sadredinamin M, Yazdansetad S, Alebouyeh M, Yazdi M, Ghalavand Z
Oman Med J. 2023; 38(4):e522.
PMID: 37724320
PMC: 10505279.
DOI: 10.5001/omj.2023.65.
Clarkson K, Porter C, Talaat K, Kapulu M, Chen W, Frenck Jr R
Curr Top Microbiol Immunol. 2022; 445:257-313.
PMID: 35616717
PMC: 7616482.
DOI: 10.1007/82_2021_248.
Teh M, Furevi A, Widmalm G, Morona R
J Bacteriol. 2020; 202(24).
PMID: 32989087
PMC: 7685545.
DOI: 10.1128/JB.00363-20.
Iguchi A, Nishii H, Seto K, Mitobe J, Lee K, Konishi N
J Clin Microbiol. 2020; 58(11).
PMID: 32817086
PMC: 7587089.
DOI: 10.1128/JCM.01493-20.
Knirel Y, Wang J, Luo X, Senchenkova S, Lan R, Shpirt A
BMC Microbiol. 2014; 14:266.
PMID: 25327486
PMC: 4206707.
DOI: 10.1186/s12866-014-0266-7.
Serotype-converting bacteriophage SfII encodes an acyltransferase protein that mediates 6-O-acetylation of GlcNAc in Shigella flexneri O-antigens, conferring on the host a novel O-antigen epitope.
Sun Q, Knirel Y, Wang J, Luo X, Senchenkova S, Lan R
J Bacteriol. 2014; 196(20):3656-66.
PMID: 25112477
PMC: 4187690.
DOI: 10.1128/JB.02009-14.
Diversity of o-antigen repeat unit structures can account for the substantial sequence variation of wzx translocases.
Hong Y, Reeves P
J Bacteriol. 2014; 196(9):1713-22.
PMID: 24532778
PMC: 3993327.
DOI: 10.1128/JB.01323-13.
Identification of an O-acyltransferase gene (oacB) that mediates 3- and 4-O-acetylation of rhamnose III in Shigella flexneri O antigens.
Wang J, Knirel Y, Lan R, Senchenkova S, Luo X, Perepelov A
J Bacteriol. 2014; 196(8):1525-31.
PMID: 24509314
PMC: 3993362.
DOI: 10.1128/JB.01393-13.
Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1-4-year-old Israeli children.
Passwell J, Ashkenazi S, Banet-Levi Y, Ramon-Saraf R, Farzam N, Lerner-Geva L
Vaccine. 2010; 28(10):2231-2235.
PMID: 20056180
PMC: 6503522.
DOI: 10.1016/j.vaccine.2009.12.050.
O-Acetylation in the O-specific polysaccharide isolated from Shigella flexneri serotype 2a.
Kubler-Kielb J, Vinogradov E, Chu C, Schneerson R
Carbohydr Res. 2006; 342(3-4):643-7.
PMID: 17087926
PMC: 1885374.
DOI: 10.1016/j.carres.2006.09.017.
Identification, characterization, and variation in expression of two serologically distinct O-antigen epitopes in lipopolysaccharides of Campylobacter fetus serotype A strains.
Brooks B, Robertson R, Lutze-Wallace C, Pfahler W
Infect Immun. 2001; 69(12):7596-602.
PMID: 11705938
PMC: 98852.
DOI: 10.1128/IAI.69.12.7596-7602.2001.
Clostridium difficile recombinant toxin A repeating units as a carrier protein for conjugate vaccines: studies of pneumococcal type 14, Escherichia coli K1, and Shigella flexneri type 2a polysaccharides in mice.
Pavliakova D, Moncrief J, Lyerly D, Schiffman G, Bryla D, Robbins J
Infect Immun. 2000; 68(4):2161-6.
PMID: 10722615
PMC: 97399.
DOI: 10.1128/IAI.68.4.2161-2166.2000.
Treatment with succinic anhydride improves the immunogenicity of Shigella flexneri type 2a O-specific polysaccharide-protein conjugates in mice.
Pavliakova D, Chu C, Bystricky S, Tolson N, Shiloach J, Kaufman J
Infect Immun. 1999; 67(10):5526-9.
PMID: 10496944
PMC: 96919.
DOI: 10.1128/IAI.67.10.5526-5529.1999.
Specificity of monoclonal antibodies elicited by mucosal infection of BALB/c mice with virulent Shigella flexneri 2a.
Hartman A, Van De Verg L, Mainhart C, Tall B
Clin Diagn Lab Immunol. 1996; 3(5):584-9.
PMID: 8877140
PMC: 170411.
DOI: 10.1128/cdli.3.5.584-589.1996.
Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids.
Taylor D, Trofa A, Sadoff J, Chu C, Bryla D, Shiloach J
Infect Immun. 1993; 61(9):3678-87.
PMID: 8359890
PMC: 281064.
DOI: 10.1128/iai.61.9.3678-3687.1993.
Comparison of conjugates composed of lipopolysaccharide from Shigella flexneri type 2a detoxified by two methods and bound to tetanus toxoid.
Polotsky V, Robbins J, Bryla D, Schneerson R
Infect Immun. 1994; 62(1):210-4.
PMID: 8262629
PMC: 186088.
DOI: 10.1128/iai.62.1.210-214.1994.
Expression of Shigella dysenteriae serotype 1 O-antigenic polysaccharide by Shigella flexneri aroD vaccine candidates and different S. flexneri serotypes.
Falt I, Schweda E, Klee S, Singh M, Floderus E, Timmis K
J Bacteriol. 1995; 177(18):5310-5.
PMID: 7545156
PMC: 177324.
DOI: 10.1128/jb.177.18.5310-5315.1995.
Monoclonal antibodies specific for O-antigenic polysaccharides of Shigella flexneri: clones binding to II, II:3,4, and 7,8 epitopes.
Carlin N, Lindberg A
J Clin Microbiol. 1983; 18(5):1183-9.
PMID: 6196376
PMC: 272864.
DOI: 10.1128/jcm.18.5.1183-1189.1983.
Quality of commercially produced Shigella serogrouping and serotyping antisera.
Evins G, Gheesling L, Tauxe R
J Clin Microbiol. 1988; 26(3):438-42.
PMID: 3281972
PMC: 266309.
DOI: 10.1128/jcm.26.3.438-442.1988.
Monoclonal antibodies specific for Shigella flexneri lipopolysaccharides: clones binding to type IV, V, and VI antigens, group 3,4 antigen, and an epitope common to all Shigella flexneri and Shigella dysenteriae type 1 stains.
Carlin N, Lindberg A
Infect Immun. 1987; 55(6):1412-20.
PMID: 2437036
PMC: 260529.
DOI: 10.1128/iai.55.6.1412-1420.1987.